Latest Posts
About This Stock
More About This Stock
Read
Read
3 ‘Strong Buy’ Biotechs That Can Double In 2018
Article By:
TipRanks
Sunday, March 11, 2018 1:00 PM EDT
Biotech stocks often present intriguing investment opportunities- although the rewards can be quickly eradicated if key regulatory approvals are delayed or refused. To minimize the risk, we pinpoint these three compelling stocks.
TG Therapeutics, Inc. Announces Pricing Of $50 Million Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Thursday, March 9, 2017 3:48 PM EDT
TG Therapeutics, Inc., today announced the pricing of an underwritten public offering of 5,128,206 shares of its common stock at a price of $9.75 per share, with expected gross proceeds to TG Therapeutics of $50 million.
In this article: TGTX